Although the mechanism and significance underlying the observed differences in SLE patients cannot be inferred from the studies published until now, it is interesting to note that while GAS6 follows the soluble TAM receptors, augmenting SLE, ProS does not. The gene discussed is GAS6; the disease is systemic lupus erythematosus.